- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Agriculture business drives successful start to year: Bayer
The CEO reiterated earlier guidance for 2022 core earnings per share to reach about 7.00 euros, up from 6.51 euros last year, excluding the effect of currency swings.
Frankfurt: German diversified group Bayer has seen a "very successful start to the year", driven by favourable agricultural markets, it said on Monday.
"In the agriculture business, in particular, we see a much more positive market environment than in previous years," Chief Executive Werner Baumann said in a written speech posted on the company's website on Monday.
The speech will be delivered at the annual shareholder meeting scheduled for Friday.
The maker of pharmaceuticals, seeds and pesticides added the economic consequences of the war in Ukraine and sanctions imposed on Russia were not yet visible in the first quarter.
The CEO reiterated earlier guidance for 2022 core earnings per share to reach about 7.00 euros ($7.50), up from 6.51 euros last year, excluding the effect of currency swings.
Read also: Bayer launches campaign 'Preserve The Uterus' to stall untimely hysterectomies in India
Baumann added that despite global uncertainties he was confident of a very successful year.
Bayer is due to release detailed first-quarter figures on May 10.
Read also: Bayer appoints Tara Frenkl as new head of oncology development at oncology strategic business unit
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751